Epibiotech Co., Ltd. (XKON:446440)
14,070
+370 (2.70%)
At close: Jun 18, 2026
39.44% (1Y)
| Market Cap | 31.10B +25.5% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7 |
| Open | 14,070 |
| Previous Close | 13,700 |
| Day's Range | 14,070 - 14,070 |
| 52-Week Range | 9,600 - 20,900 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |